Literature DB >> 10234603

Molecular water pumps and the aetiology of Canavan disease: a case of the sorcerer's apprentice.

M H Baslow1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10234603     DOI： 10.1023/a:1005437915117

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  11 in total

Review 1.  Molecular basis of Canavan disease.

Authors:  R Matalon; K Michals-Matalon
Journal:  Eur J Paediatr Neurol       Date:  1998       Impact factor: 3.140

2.  The human Na+-glucose cotransporter is a molecular water pump.

Authors:  A Meinild; D A Klaerke; D D Loo; E M Wright; T Zeuthen
Journal:  J Physiol       Date:  1998-04-01       Impact factor: 5.182

3.  The clinical course of Canavan disease.

Authors:  E C Traeger; I Rapin
Journal:  Pediatr Neurol       Date:  1998-03       Impact factor: 3.372

4.  Gene therapy in New Zealand.

Authors:  M During
Journal:  Science       Date:  1996-04-26       Impact factor: 47.728

Review 5.  Metabolic coupling between glia and neurons.

Authors:  M Tsacopoulos; P J Magistretti
Journal:  J Neurosci       Date:  1996-02-01       Impact factor: 6.167

Review 6.  Canavan disease. Analysis of the nature of the metabolic lesions responsible for development of the observed clinical symptoms.

Authors:  M H Baslow; T R Resnik
Journal:  J Mol Neurosci       Date:  1997-10       Impact factor: 3.444

Review 7.  Glial calcium: homeostasis and signaling function.

Authors:  A Verkhratsky; R K Orkand; H Kettenmann
Journal:  Physiol Rev       Date:  1998-01       Impact factor: 37.312

Review 8.  A review of phylogenetic and metabolic relationships between the acylamino acids, N-acetyl-L-aspartic acid and N-acetyl-L-histidine, in the vertebrate nervous system.

Authors:  M H Baslow
Journal:  J Neurochem       Date:  1997-04       Impact factor: 5.372

9.  Aquaporin-4 water channel protein in the rat retina and optic nerve: polarized expression in Müller cells and fibrous astrocytes.

Authors:  E A Nagelhus; M L Veruki; R Torp; F M Haug; J H Laake; S Nielsen; P Agre; O P Ottersen
Journal:  J Neurosci       Date:  1998-04-01       Impact factor: 6.167

10.  Function of the N-acetyl-L-histidine system in the vertebrate eye. Evidence in support of a role as a molecular water pump.

Authors:  M H Baslow
Journal:  J Mol Neurosci       Date:  1998-06       Impact factor: 3.444
View more
  19 in total

Review 1.  Clinical applications involving CNS gene transfer.

Authors:  Boris Kantor; Thomas McCown; Paola Leone; Steven J Gray
Journal:  Adv Genet       Date:  2014       Impact factor: 1.944

2.  Structure of aspartoacylase, the brain enzyme impaired in Canavan disease.

Authors:  Eduard Bitto; Craig A Bingman; Gary E Wesenberg; Jason G McCoy; George N Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-28       Impact factor: 11.205

3.  Effects of ethanol and of alcohol dehydrogenase inhibitors on the reduction of N-acetylaspartate levels of brain in mice in vivo: a search for substances that may have therapeutic value in the treatment of Canavan disease.

Authors:  M H Baslow; R F Suckow; B L Hungund
Journal:  J Inherit Metab Dis       Date:  2000-11       Impact factor: 4.982

4.  Metabolic acetate therapy improves phenotype in the tremor rat model of Canavan disease.

Authors:  Peethambaran Arun; Chikkathur N Madhavarao; John R Moffett; Kristen Hamilton; Neil E Grunberg; Prasanth S Ariyannur; William A Gahl; Yair Anikster; Steven Mog; William C Hallows; John M Denu; Aryan M A Namboodiri
Journal:  J Inherit Metab Dis       Date:  2010-05-13       Impact factor: 4.982

5.  Expression of aspartoacylase activity in cultured rat macroglial cells is limited to oligodendrocytes.

Authors:  M H Baslow; R F Suckow; V Sapirstein; B L Hungund
Journal:  J Mol Neurosci       Date:  1999 Aug-Oct       Impact factor: 3.444

Review 6.  Diffusion-weighted MR imaging in leukodystrophies.

Authors:  Zoltan Patay
Journal:  Eur Radiol       Date:  2005-07-15       Impact factor: 5.315

7.  Dietary triheptanoin rescues oligodendrocyte loss, dysmyelination and motor function in the nur7 mouse model of Canavan disease.

Authors:  Jeremy S Francis; Vladimir Markov; Paola Leone
Journal:  J Inherit Metab Dis       Date:  2013-11-28       Impact factor: 4.982

8.  Long-term follow-up after gene therapy for canavan disease.

Authors:  Paola Leone; David Shera; Scott W J McPhee; Jeremy S Francis; Edwin H Kolodny; Larissa T Bilaniuk; Dah-Jyuu Wang; Mitra Assadi; Olga Goldfarb; H Warren Goldman; Andrew Freese; Deborah Young; Matthew J During; R Jude Samulski; Christopher G Janson
Journal:  Sci Transl Med       Date:  2012-12-19       Impact factor: 17.956

Review 9.  Gene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders.

Authors:  Dominic J Gessler; Guangping Gao
Journal:  Methods Mol Biol       Date:  2016

10.  rAAV Gene Therapy in a Canavan's Disease Mouse Model Reveals Immune Impairments and an Extended Pathology Beyond the Central Nervous System.

Authors:  Seemin Seher Ahmed; Stefan A Schattgen; Ashley E Frakes; Elif M Sikoglu; Qin Su; Jia Li; Thomas G Hampton; Andrew R Denninger; Daniel A Kirschner; Brian Kaspar; Reuben Matalon; Guangping Gao
Journal:  Mol Ther       Date:  2016-04-04       Impact factor: 11.454
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.